Inborn Errors of Mitochondrial Fatty Acid Oxidation

References

• Roe CR, Coates PM. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th ed. Pp. 1501–33. New York: McGraw-Hill, 1995.
   Google Scholar
• Hale DE, Bennett MJ. Fatty acid oxidation disorders: a new class of metabolic diseases. J Pediatr 1992; 121: 1–11.
   PubMedGoogle Scholar
• Schulz H. Mitochondrial P-oxidation. In: Tanaka K, Coates PM, eds. Fatty acid oxidation: clinical, biochemical and molecular aspects. Pp. 23–36. New York: Alan R. Liss, 1990.
   Google Scholar
• Stanley CA. Disorders of fatty acid oxidation. In: Fernandes J, Saudubray J-M, van den Berghe G, eds. Inborn metabolic diseases: diagnosis and treatment, 2nd ed. Pp. 133–43, 1995.
   Google Scholar
• Coates PM. New developments in the diagnosis and investigation of mitochondrial fatty acid oxidation disorders. Eur J Pediatr 1994; 153 [suppl 1]: 49–56.
   Google Scholar
• Eaton S, Bartlett KM Pourfarzam M. Mammalian mitochondrial P-oxidation. Biochem J 1996; 320: 345–57.
   PubMed Web of Science ®Google Scholar
• Saudubray J-M, Martin D, Poggi-Travert, et al. Clinical presentations of inherited mitochondrial fatty acid oxidation disorders: an update. Int Pediatr 1997; 12: 34–40.
   Google Scholar
• Bennett MJ. Fatty acid oxidation: normal metabolism and genetic disease. Diag Endo Metab 1997; 15: 11–23.
   Google Scholar
• Rinaldo P, Raymond K, Al-Odaib A, et al. Clinical and biochemical features of fatty acid oxidation disorders. Curr Opin Pediatr 1998; 10: 615–21.
   PubMedGoogle Scholar
• Schaffer JE, Lodish HF. Molecular mechanism of long-chain fatty acid uptake. Trends Cardiovasc Med 1995; 5: 218–24.
   Google Scholar
• Bremer J. Carnitine: metabolism and functions. Physiol Rev 1983; 63: 1420–80.
   PubMed Web of Science ®Google Scholar
• Rebouche CJ, Mack DL. Sodium gradient-stimulated transport of L-carnitine into renal brush border membrane vesicles: kinetics, specificity, and regulation by dietary carnitine. Arch Biochem Biophys 1984; 235: 393–402.
   PubMedGoogle Scholar
• McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 1997; 244: 1–14.
   PubMedGoogle Scholar
• Frerman FE, Goodman SI. Nuclear-encoded defects of the mitochondrial respiratory chain, including glutaric acidemia type II. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th ed. Pp. 1611–29. New York: McGraw-Hill, 1995.
   Google Scholar
• Schaffer JE, Lodish HF. Expression, cloning and characterization of a novel adipocyte fatty acid binding protein. Cell 1994; 79: 427–36.
   PubMed Web of Science ®Google Scholar
• Stemmel W, Strohmeyer G, Borchard F, et al. Isolation and characterization of fatty acid binding protein in rat liver membranes. Proc Natl Acad Sci USA 1985; 82: 4–8.
   Google Scholar
• Fuji S, Kawaguchi H, Yasuda H. Isolation and partial characterization of an amphiphilic 56-kDa fatty acid binding protein from rat renal basolateral membrane. J Biochem Biophys Res 1987; 101: 679–84.
   Google Scholar
• Trigatti BL, Mangaroo D Gerber GE. Photoaffinity labelling and fatty acid permeation in 3&3-L1 adipocytes. J Biol Chem 1991; 266: 22621–5.
   Google Scholar
• Abumrad NA, Raafat El-Maghrabi M, Ameri EZ, et al. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J Biol Chem 1993; 268: 17665–8.
   PubMed Web of Science ®Google Scholar
• Hirsch D, Stahl A, Lodish HF. A family of fatty acid transporters conserved from myco-bacterium to man. Proc Natl Acad Sci USA 1998; 95: 8625–9.
   PubMed Web of Science ®Google Scholar
• Tein I, Bukovac SW, Xie ZW. Characterization of the human plasmalemmal carnitine transporter in cultured skin fibroblasts. Arch Biochem Biophys 1996; 329: 145–55.
   Google Scholar
• Lamhonwah A-M, Tein I. Carnitine uptake defect: frameshift mutations in the human plasmalemmal carnitine transporter gene. Biochem Biophys Res Commun 1998; 252: 396–401.
   Google Scholar
• Nezu J-I, Tamai I, Oku A, et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nature Genet 1999; 21: 91–4.
   PubMed Web of Science ®Google Scholar
• Britton CH, Schultz RA, Zhang B, et al. Human liver mitochondrial carnitine palmitoyltransferase I: characterization of its cDNA and chromosomal localization and partial analysis of the gene. Proc Natl Acad Sci USA 1995; 92: 1984–8.
   PubMed Web of Science ®Google Scholar
• Britton CH, Mackay DW, Esser V, et al. Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT IA and CPT IB). Genomics 1997; 40: 209–11.
   Google Scholar
• McGarry JD. Ketogenesis and lipogenesis: metabolic integration in health and disease. Biochem Soc Trans 1995; 23: 481–5.
   Google Scholar
• Huizing M, Iacobazzi V, IJlst L, et al. Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient. Am J Hum Genet 1997; 61: 1239–45.
   PubMedGoogle Scholar
• Indiveri C, Iacobazzi V, Giangregorio N, et al. The mitochondrial carnitine carrier protein: cDNA cloning, primary structure and comparison with other mitochondrial transport proteins. Biochem J 1997; 321: 713–9.
   Google Scholar
• Finocchiaro G, Taroni F, Rocchi M, et al. cDNA cloning, sequence analysis, and chromosomal localization of the gene for human carnitine palmitoyltransferase. Proc Natl Acad Sci USA 1991; 88: 661–5 (erratum: 88: 981).
   Google Scholar
• Demaugre F, Bonnefont JP, Cepanec C, et al. Immunoquantitative analysis of human carnitine palmitoyltransferase I and II defects. Pediatr Res 1990; 27: 497–500.
   Google Scholar
• Izai K, Uchida Y, Orii T, et al. Novel fatty acid P-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain acyl coenzyme A dehydrogenase. J Biol Chem 1992; 267: 1027–33.
   PubMed Web of Science ®Google Scholar
• Andresen BS, Bross P, Vianey-Saban C, et al. Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA, chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene. Hum Mol Genet 1996; 5: 461–72.
   Google Scholar
• Uchida Y, Izai K, Orii T, et al. Novel fatty acid P-oxidation enzymes in rat liver mitochondria. II: Purification and properties of enoyl-CoA hydratase/ 3-hydroxyacyl-CoA dehydrogenase/ 3-ketoacyl-CoA thiolase trifunctional protein. J Biol Chem 1992; 267: 1034–41.
   PubMed Web of Science ®Google Scholar
• Carpenter K, Pollitt RJ, Middleton B. Human long-chain 3-hydroxyacyl-CoA dehydrogenase is a multifunctional membrane-bound P-oxidation enzyme of mitochondria. Biochem Biophys Res Commun 1992; 183: 443–8.
   PubMedGoogle Scholar
• Ushikubo S, Aoyama T, Kamijo T, et al. Molecular characterization of mitochondrial trifunctional protein deficiency: formation of the enzyme complex is important for stabilization of both alpha and beta subunits. Am J Hum Genet 1996; 58: 979–88.
   Google Scholar
• Weinberger MJ, Rinaldo P, Strauss AW, et al. Intact a-subunit is required for membrane-binding of human mitochondrial trifunctional P-oxidation protein, but is not necessary for conferring 3-ketoacyl-CoA thiolase activity to the P-subunit. Biochem Biophys Res Commun 1995; 209: 47–52.
   Google Scholar
• IJlstL, Ruiter JPN, Hoovers JMN, et al. Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency-characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mito-chondrial trifunctional protein alpha subunit gene. J Clin Invest 1996; 98: 1028–33.
   Google Scholar
• Sims HF, Brackett JC, Powell CK, et al. The molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA 1995; 92: 841–5.
   PubMed Web of Science ®Google Scholar
• Ushikubo S, Aoyama T, Kamijo T, et al. Molecular characterization of mitochondrial trifunctional protein deficiency. Am J Hum Genet 1996; 58: 979–88.
   Google Scholar
• Indo Y, Yang-Feng TL, Glassberg R, et al. Molecular cloning and nucleotide sequence of cDNA's encoding human long-chain acyl-CoA dehydrogenase and assignment of the location of the gene (ACADL) to chromosome 2. Genomics 1991; 11: 609–20.
   Google Scholar
• Matsubara Y, Kraus JP, Yang-Feng TL, et al. Molecular cloning of cDNA's encoding rat and human medium-chain acyl-CoA dehydrogenase and assignment of the gene to human chromosome 1. Proc Natl Acad Sci USA 1986; 83: 6543–7.
   Web of Science ®Google Scholar
• Kelly DP, Kim J-J, Billadello JJ, et al. Nucleotide sequence of medium-chain acyl-CoA dehydrogenase mRNA and its expression in enzyme-deficient human tissue. Proc Natl Acad Sci USA 1987; 84: 4068–72.
   PubMedGoogle Scholar
• Naito E, Ozasa H, Ikeda Y, et al. Molecular cloning and nucleotide sequence of complementary cDNA's encoding human short-chain acyl-CoA dehydrogenase and the study of the molecular basis of short-chainacyl-CoA dehydrogenase deficiency. J Clin Invest 1989; 83: 1605–13.
   PubMed Web of Science ®Google Scholar
• Vredendaal PJCM, van den Berg IET, Malingre HEM, et al. Human short-chain L-3-hydroxy acyl-CoA dehydrogenase: cloning and characterization of the coding sequence. Biochem Biophys Res Commun 1996; 223: 718–23.
   Google Scholar
• Kamijo T, Indo Y, Souri M, et al. Medium chain 3-ketoacyl-Coenzyme A thiolase deficiency: a new disorder of fatty acid P-oxidation. Pediatr Res 1997; 42: 569–76.
   Google Scholar
• Fukao T, Kamijo K, Osumi T, et al. Molecular cloning and nucleotide sequence of cDNA encoding the entire precursor of rat mitochondrial acetoacetyl-CoA thiolase. J Biochem 1989; 106: 197–204.
   Google Scholar
• Kobayashi A, Jiang LL Hashimoto T. Two mitochondrial 3-hydroxyacyl-CoA dehydroge-nases in bovine liver. J Biochem 1996; 119: 775–82.
   Google Scholar
• Furuta S, Kobayashi A, Miyazama S et al. Cloning and expression of cDNA for a newly identified isozyme of bovine liver 3-hydroxyacyl-CoA dehydrogenase and its import into mitochondria. Biochim Biophys Acta 1997; 1350: 317–24.
   Google Scholar
• DiMauro S, DiMauro PMM. Muscle carnitine palmitoyltransferase deficiency and myoglo-binuria. Science 1973; 182: 929–31.
   PubMed Web of Science ®Google Scholar
• Taroni F, Verderio E, Dworzak F, et al. Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients. Nature Genet 1993; 4: 314–20.
   PubMed Web of Science ®Google Scholar
• Bonnefont J-P, Taroni F, Cavadini P, et al. Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatomuscular expression. Am J Hum Genet 1996; 58: 971–8.
   PubMed Web of Science ®Google Scholar
• Sue CM, Hirano M, DiMauro S, et al. Neonatal presentations of mitochondrial metabolic disorders. Semin Perinatol 1999; 23: 113–24.
   Google Scholar
• Tripp ME, KatcherML, Peters HA, et al. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy. N Engl J Med 1981; 305: 385–90.
   PubMed Web of Science ®Google Scholar
• Waber LJ, Valle D, Neill C, et al. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr 1982; 101: 700–4.
   PubMed Web of Science ®Google Scholar
• Treem WR, Stanley CA, Finegold DN, et al. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts. N Engl J Med 1988; 319: 1331–6.
   PubMed Web of Science ®Google Scholar
• Stanley CA, Deleeuw S, Coates PM, et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol 1991; 30: 709–16.
   Google Scholar
• Tein I, DeVivo DC, Bierman F, et al. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopa-thy. Pediatr Res 1990; 28: 247–55.
   PubMed Web of Science ®Google Scholar
• Bennett MJ, Hale DE, Pollitt RJ, et al. Endocardial fibroelastosis and primary carnitine deficiency due to a defect in the plasma membrane carnitine transporter. Clin Cardiol 1996; 19: 243–6.
   Google Scholar
• Rinaldo P, Stanley CA, Hsu BYL, et al. Sudden neonatal death in carnitine transporter deficiency. J Pediatr 1997; 131: 304–5.
   PubMed Web of Science ®Google Scholar
• Bougneres P-F, Saudubray J-M, Marsac C, et al. Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr 1981; 98: 742–6.
   Google Scholar
• Demaugre F, Bonnefont JP Mitchell G. Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities. Pediatr Res 1988; 24: 308–11.
   PubMed Web of Science ®Google Scholar
• Falik-Borenstein ZC, Jordan SC, Saudubray J-M, et al. Renal tubular acidosis in carnitine palmitoyltransferase type I deficiency. N Engl J Med 1992; 327: 24–7.
   Google Scholar
• Bergman AJIW, Donckerwolcke RAMG, Duran M, et al. Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency. Pediatr Res 1994; 36: 5828.
   Google Scholar
• IJlst L, Mandel H, Oostheim W, et al. Molecular basis of hepatic carnitine palmitoyltransferase I deficiency. J Clin Invest 1998; 102: 527–31.
   Google Scholar
• Stanley CA, Hale DE, Berry GT, et al. A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. N Engl J Med 1992; 327: 19–23.
   PubMed Web of Science ®Google Scholar
• Pande SV, Brivet M, Slama A, et al. Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculoventricular block: translocase assay in permeabilized fibroblasts. J Clin Invest 1993; 91: 1247–52.
   Google Scholar
• Brivet M, Slama A, Ogier H, et al. Diagnosis of carnitine-acylcarnitine translocase deficiency by complementation analysis. JInher Metab Dis 1995; 17: 271–4.
   Google Scholar
• Ogier de Baulny H, Slama A, Touati G, et al. Neonatal hyperammonemia caused by a defect of carnitine-acylcarnitine translocase. J Pediatr 1995; 127: 723–8.
   Google Scholar
• Demaugre F, Bonnefont J-P, Colonna M, et al. Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. J Clin Invest 1991; 87: 859–64.
   PubMed Web of Science ®Google Scholar
• Hug G, Bove KE Soukup S. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. N Engl J Med 1991; 325: 1862–4.
   PubMed Web of Science ®Google Scholar
• North KN, Hoppel CL, De Girolami U, et al. Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. J Pediatr 1995; 127: 414–20.
   Google Scholar
• Elpeleg ON, Joseph A, Branski D, et al. Recurrent metabolic decompensation in profound carnitine palmitoyltransferase II deficiency. J Pediatr 1993; 122: 917–9.
   PubMed Web of Science ®Google Scholar
• Verderio E, Cavadini P, Montermini L, et al. Carnitine palmitoyltransferase II deficiency: structure of the gene and characterization of two novel disease-causing mutations. Hum Mol Genet 1995; 4: 19–29.
   Google Scholar
• Hale DE, Batshaw M, Coates PM, et al. Long-chain acyl-CoA dehydrogenase deficiency: a cause of non-ketotic hypoglycemia. Pediatr Res 1985; 19: 666–71.
   PubMed Web of Science ®Google Scholar
• Treem WR, Witzleben CA, Piccoli DA, et al. Medium-chain and long-chain acyl-CoA dehydrogenase deficiencies: clinical, pathological and ultrastructural differentiation from Reye's syndrome. Hepatology 1986; 6: 1270–8.
   PubMed Web of Science ®Google Scholar
• Allison F, Bennett MJ, Variend S, et al. Acyl-CoA dehydrogenase deficiency in heart tissue from infants who died suddenly and unexpectedly, with fatty change in liver. Brit Med J 1988; 296: 11–2.
   PubMedGoogle Scholar
• Eder M, Krautle F, Dong Y, et al. Characterization of human and pig kidney LCAD and their role in P-oxidation. Eur J Biochem 1997; 245: 600–7.
   Google Scholar
• Largilliere C, Vianey-Saban C, Fontaine M, et al. Mitochondrial very long chain acyl-CoA dehydrogenase deficiency—a new disorder of fatty acid oxidation. Arch Dis Child 1995; 73: F103–5.
   Google Scholar
• Aoyama T, Uchida Y, Kellet RI, et al. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. Biochem Biophys Res Commun 1993; 191: 1369–72.
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Indo Y, Coates PM, et al. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 1993; 34: 111–3.
   Google Scholar
• Strauss AW, Powell CK, Hale DE, et al. Molecular basis of human mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. Proc Natl Acad Sci USA 1995; 92: 10496—500.
   PubMed Web of Science ®Google Scholar
• Souri M, Aoyama T, Orii K, et al. Mutation analysis of very-long-chain acyl-Coenzyme A dehydrogenase (VLCAD) deficiency: identification and characterization of mutant VLCAD cDNA's from four patients. Am J Hum Genet 1996; 58: 97–106.
   Google Scholar
• Andresen BS, Olpin S, PoorthuisBJHM, et al. Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet 1999; 64: 479–94.
   PubMed Web of Science ®Google Scholar
• Mathur A, Sims HF, Gopalakrishnan D, et al.Molecular heterogeneity in VLCAD deficiency causing pediatric cardiomyopathy and sudden death. Circulation 1999; 99: 1337–43.
   PubMed Web of Science ®Google Scholar
• Ogilvie I, Pourfarzam M, Jackson S, et al. Very-long-chain acyl-coenzyme A dehydrogenase deficiency presenting as exercise-induced myoglobinuria. Neurology 1994;44:467–73.
   Google Scholar
• Kurtz D, Rinaldo P, Rhead WJ, et al. Targeted disruption of mouse long-chain acyl-CoA dehydrogenase reveals a crucial role in fatty acid oxidation. Proc Natl Acad Sci USA 1998; 95: 15592–7.
   PubMed Web of Science ®Google Scholar
• Tyni T, Pihko H. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Acta Paediatr 1999; 88: 237–45.
   PubMed Web of Science ®Google Scholar
• Wanders RJA, Duran M, IJlst L, et al. Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a new inborn error of fatty acid P-oxidation. Lancet 1989; I: 52–3.
   Google Scholar
• Wanders RJA, IJlst L, van Gennip AH, et al. Long-chain 3-hydroxyacyl-CoA dehydroge-nase deficiency: identification of a new inborn error of mitochondrial fatty acid P-oxida-tion. J Inher Metab Dis 1990; 13: 311–4.
   PubMed Web of Science ®Google Scholar
• Hale DE, Thorpe C, Braat K, et al. The L-3-hydoxyacyl-CoA dehydrogenase deficiency. In: Tanaka K, Coates PM, eds. Fatty acid oxidation: clinical, biochemical and molecular aspects. Pp. 503–10. New York: Alan R. Liss, 1990.
   Google Scholar
• Jackson S, Bartlett K, Land J, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res 1991; 29: 406–11.
   PubMed Web of Science ®Google Scholar
• Przyrembel H, Jacobs C, IJlst L, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inher Metab Dis 1991; 14: 674–80.
   PubMed Web of Science ®Google Scholar
• Rocchiccioli F, Wanders RJA, Auberg P, et al. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 1990; 28: 657–62
   PubMed Web of Science ®Google Scholar
• Moore R, Glasgow JFT, Bingham MA, et al. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency-diagnosis, plasma carnitine fractions and management in a further patient. Eur J Pediatr 1993; 152: 433–6.
   Google Scholar
• Dionisi Vici C, Burlina AB, Bertini E, et al. Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Pediatr 1991; 118: 744–6.
   Google Scholar
• Amirkham R, Timmons C, Brown K, et al. Clinical, biochemical, and morphologic investigations of a case of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Arch Pathol Lab Med 1997; 121: 730–4.
   Google Scholar
• Tyni T, Palotie A, Viinikka L, et al. Long-chain 3-hydroxyacyl coenzyme A deficiency with the G1528C mutation: clinical presentation of thirteen patients. J Pediatr 1997; 130: 67–76.
   PubMed Web of Science ®Google Scholar
• Sewell AC, Bender SW, Wirth S, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder. Eur J Pediatr 1994; 153: 745–50.
   Google Scholar
• Martins E, Costa A, Silva E, et al. Lethal dilated cardiomyopathy due to long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inher Metab Dis 1996; 19: 373–4.
   Google Scholar
• Schrijver-Wieling I, van Rens G, Wittebol-Post D, et al. Retinal dystrophy in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Br J Ophthalmol 1997; 81: 291–4.
   PubMedGoogle Scholar
• Pons R, Roig M, Riudor E, et al. The clinical spectrum of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Neurol 1996; 14: 236–43.
   PubMedGoogle Scholar
• Jackson S, Singh-Kler R, Bartlett K, et al. Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest 1992; 90: 1219–25.
   PubMedGoogle Scholar
• Isaacs JJ, Sims HF, Powell CK, et al. Maternal acute fatty liver of pregnancy associated with fetal trifunctional protein deficiency: molecular characterization of a novel maternal mutant allele. Pediatr Res 1996; 40: 393–8.
   Google Scholar
• Brackett JC, Sims HF, Rinaldo P, et al. Two a subunit donor splice site mutations cause human trifunctional protein deficiency. J Clin Invest 1995; 95: 2076–82.
   Google Scholar
• Orii K, Aoyama T, Wakui K, et al. Genomic and mutational analysis of the mitochondrial trifunctional protein P-subunit (HADHB) gene in patients with trifunctional protein deficiency. Hum Mol Genet 1997; 6: 1215–24.
   PubMed Web of Science ®Google Scholar
• Schaefer J, Jackson S, Dick D, et al. Trifunctional protein deficiency: adult presentation of a usually fatal P-oxidation defect. Ann Neurol 1996; 40: 597–602.
   Google Scholar
• Miyajima H, Orii K, Shindo Y, et al. Mitochondrial trifunctional protein deficiency associated with recurrent myoglobinuria in adolescence. Neurology 1997; 49: 833–7.
   Google Scholar
• Ibdah JA, Tein I, Dionisi-Vici C, et al. Mild trifunctional protein deficiency is associated with progressive neuropathy and suggests a novel genotype-phenotype correlation. J Clin Invest 1998; 102: 119–9.
   Google Scholar
• Wolf JL. Liver disease in pregnancy. Med Clin North Am 1996; 80: 1167–87.
   PubMed Web of Science ®Google Scholar
• Knox TA, Olans LB. Liver disease in pregnancy. New Engl J Med 1996; 335: 569–76.
   PubMed Web of Science ®Google Scholar
• Schoeman MN, Batey RG Wilcken B. Recurrent acute fatty liver of pregnancy associated with a fatty acid oxidation defect in the offspring. Gastroenterology 1991; 100: 544–8.
   PubMed Web of Science ®Google Scholar
• Wilcken B, Leung K-C, Hammond J, et al. Pregnancy and fetal long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Lancet 1993; 341: 407–8.
   PubMedGoogle Scholar
• Treem WR, Rinaldo P, Hale DE, et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Hepatol 1994; 19: 339–45.
   PubMed Web of Science ®Google Scholar
• Treem WR, Shoup ME, Hale DE, et al. Acute fatty liver of pregnancy, HELLP, and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Am J Gastroenterol 1996; 91: 2293300.
   Google Scholar
• Tyni T, Ekholm E Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Am J Obstet Gynecol 1998; 178: 603–8.
   PubMed Web of Science ®Google Scholar
• Strauss AW, Bennett MJ, Rinaldo P, et al. Inherited long-chain 3-hydroxyacyl-CoA dehy-drogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications. Semin Perinatol 1999; 23: 100–12.
   PubMed Web of Science ®Google Scholar
• Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med (in press).
   Google Scholar
• Hicks P, Bennett MJ, Squires J, et al. Heterozygosity for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and deteriorating liver function in an HIV-infected newborn. J Pediatr 1995; 127: 599–602.
   Google Scholar
• Divry P, David M, Gregersen N, et al. Dicarboxylic aciduria due to medium-chain acyl-CoA Dehydrogenase defect. A cause of hypoglycemia in childhood. Acta Paediatr Scand 1983; 72: 943–9.
   Google Scholar
• Stanley CA, Hale DE, Coates PM, et al. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr Res 1983; 17: 877–84.
   PubMed Web of Science ®Google Scholar
• Rhead WJ, Amendt BA, Fritchman KS, et al. Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts. Science 1983; 221: 73–5.
   Google Scholar
• Iafolla AK, Thompson RJJ Roe CR. Medium-chain acylcoenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 1994; 124: 409–15.
   PubMed Web of Science ®Google Scholar
• Howat AJ, Bennett MJ, Shaw L, et al. Deficiency of medium-chain acyl-CoA dehydroge-nase presenting as sudden infant death syndrome. Br Med J 1984; 288: 976.
   Google Scholar
• Howat AJ, Bennett MJ, Variend S, et al. Defects of metabolism of fatty acids in the sudden infant death syndrome. Br Med J 1985; 290: 1771–3.
   PubMedGoogle Scholar
• Duran M, Hofkamp M, Rhead WJ et al. Sudden child death and “healthy” affected members with medium-chain acyl-CoA dehydrogenase deficiency. Pediatrics 1986; 78: 1052–7.
   PubMedGoogle Scholar
• Roe CR, Millington DS, Maltby DA, et al. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes. J Pediatr 1986; 108: 13–8.
   PubMed Web of Science ®Google Scholar
• Blakemore AIF, Singleton H, Pollitt RJ, et al. Frequency of the G985 MCAD mutation in the general population. Lancet 1991; 337: 298–9.
   Google Scholar
• Matsubara Y, Narisawa K, Tada K, et al. Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards. Lancet 1991; 338: 552–3.
   PubMedGoogle Scholar
• Kolvraa S, Gregersen N, Blakemore AIF, et al. The most common mutation causing medium-chain acyl-CoA dehydrogenase deficiency is strongly associated with a particular haplotype in the region of the gene. Hum Genet 1991; 87: 425.
   Google Scholar
• Matsubara Y, Narisawa K, Miyabayashi S, et al. Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency. Biochem Biophys Res Commun 1990; 171: 498–505.
   PubMed Web of Science ®Google Scholar
• Kelly DP, Whelan AJ, Ogden ML, et al. Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency. Proc Natl Acad Sci USA 1990; 87: 9236–40.
   PubMed Web of Science ®Google Scholar
• Chase DH, Hillman SL, Van Hove JKL, et al. Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clin Chem 1997; 43: 2106–13.
   Google Scholar
• Ziadeh R, Hoffman EP, Finegold DN, et al. Medium-chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows a high incidence and unexpected mutation frequencies. Pediatr Res 1995; 37: 675–8.
   PubMed Web of Science ®Google Scholar
• Amendt BA, Greene C, Sweetman L, et al. Short-chain acyl-CoA dehydrogenase deficiency. Clinical and biochemical studies in two patients. J Clin Invest 1987; 79: 1303–9.
   PubMed Web of Science ®Google Scholar
• Coates PM, Hale DE, Finocchiaro G, et al. Genetic deficiency of short-chain acyl-coen-zyme A dehydrogenase in cultured fibroblasts from a patient with muscle carnitine deficiency and severe skeletal muscle weakness. J Clin Invest 1988; 81: 171–5.
   PubMed Web of Science ®Google Scholar
• Sewell AC, Herwig J, Bohles H, et al. A new case of short-chain acyl-CoA dehydrogenase deficiency with isolated ethylmalonic aciduria. Eur J Pediatr 1993; 152: 922–4.
   PubMed Web of Science ®Google Scholar
• Dawson DB, Waber L, Hale DE, et al. Transient organic aciduria and persistent lacticacidemia in a patient with short-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 1995; 126: 69–71.
   Google Scholar
• Baerlocher KE, Steinmann B, Aguzzi A, et al. Short-chain acyl-CoA dehydrogenase deficiency in a 16-year-old girl with severe muscle wasting and scoliosis. J Inher Metab Dis 1997; 20: 427–31.
   Google Scholar
• Bhala A, Willi SM, Rinaldo P, et al. Clinical and biochemical characterization of short-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 1995; 126: 910–5.
   Google Scholar
• Gregersen N, Winter VS, Corydon MJ, et al. Identification of four new mutations in the short-chain acyl-CoA dehydrogenase gene in two patients: one of the variant alleles, 511C to T, is present at an unexpectedly high frequency in the general population, as was the case for 625G to A, together conferring susceptibility to ethylmalonic aciduria. Hum Mol Genet 1998; 7: 619–27.
   Google Scholar
• Corydon MJ, Gregersen N, Lehnert W, et al. Ethylmalonic aciduria is associated with an amino acid variant of short-chain acyl-CoA dehydrogenase. Pediatr Res 1996; 39: 105966.
   Google Scholar
• Al Odaib A, Schneider BL, Bennett MJ, et al. A defect in the transport of long-chain fatty acids associated with acute liver failure. N Engl J Med 1998; 339: 1752–7.
   Google Scholar
• Tein I, De Vivo DC, Hale De, et al. Short-chain L 3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause of recurrent myoglobinuria and encephalopathy. Ann Neurol 1991; 30: 415–9.
   PubMedGoogle Scholar
• Bennett MJ, Weinberger MJ, Kobori JA, et al. Mitochondrial short-chain L 3-hydroxybutyryl-CoA dehydrogenase deficiency: a new defect of fatty acid oxidation. Pediatr Res 1996; 39: 185–8.
   Google Scholar
• Bennett MJ, Spotswood SD, Ross KF, et al. Fatal hepatic short-chain L 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical, biochemical and pathological studies on three subjects with this recently identified disorder of mitochondrial P-oxidation. Pediatr Dev Pathol 1999; in press.
   Google Scholar
• Kamijo T, Indo I, Souri M, et al. Medium-chain 3-ketoacyl-CoA thiolase deficiency: a new disorder of mitochondrial fatty acid P-oxidation. Pediatr Res 1997; 42: 569–76.
   Google Scholar
• Roe CR, Millington DS, Norwood DL, et al. 2,4-Dienoyl-coenzyme A reductase deficiency: a possible new disorder of fatty acid oxidation. J Clin Invest 1990; 85: 1703.
   PubMedGoogle Scholar
• Sweetman L, Williams JC. Branched chain organic acidurias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th ed. Pp. 1387–1422. New York: McGraw-Hill, 1995.
   Google Scholar
• Thompson GN, Hsu BYL, Pitt JJ, et al. Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. N Engl J Med 1997; 337: 1203–7.
   Google Scholar
• Bennett MJ. The laboratory diagnosis of inborn errors of fatty acid oxidation. Ann Clin Biochem 1990; 27: 519–31.
   Google Scholar
• Rinaldo P, O'Shea JJ, Coates PM, et al. Medium-chain acyl-CoA dehydrogenase deficiency: diagnosis by stable isotope dilution analysis of urinary n-hexanoylglycine and 3-phenylpropionylglycine. N Engl J Med 1988; 319: 1308–13.
   PubMed Web of Science ®Google Scholar
• Millington DS, Terada N, Chase DH, et al. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. In: Coates PM, Tanaka K, eds. New developments in fatty acid oxidation. Pp. 339–54. New York: Wiley-Liss, 1992.
   Google Scholar
• Pollitt RJ. Clinical and biochemical presentations in 20 cases of hydroxydicarboxylic aciduria. In: Tanaka K, Coates PM, eds. Fatty acid oxidation: clinical, biochemical and molecular aspects. Pp. 495–502. New York: AR Liss, 1990.
   Google Scholar
• Bennett MJ, Sherwood WG, Gibson KM, et al. Secondary inhibition of multiple NAD-requiring dehydrogenase enzymes in respiratory chain complex I deficiency: possible metabolic markers for the primary defect. J Inher Metab Dis 1993; 16: 560–2.
   Google Scholar
• Bennett MJ, Weinberger MJ, Sherwood WG, et al. Secondary 3-hydroxydicarboxylic aciduria mimicking long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inher Metab Dis 1994; 17: 283–6.
   PubMedGoogle Scholar
• Saudubray J-M, Coude F-X, Demaugre F, et al. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation. Pediatr Res 1982; 16: 877–81.
   Google Scholar
• Rhead WJ. Screening for inborn errors of fatty acid oxidation in cultured fibroblasts: an overview. In: Tanaka K, Coates PM, eds. Fatty acid oxidation: clinical, biochemical and molecular aspects. Pp. 365–82. New York: AR Liss, 1990.
   Google Scholar
• Manning NJ, Olpin SE, Pollitt RJ, et al. A comparison of [9,10-3H] palmitic and [9,10-3H] myristic acids for the detection of fatty acid oxidation defects in intact cultured fibroblasts. J Inher Metab Dis 1990; 13: 58–68.
   Google Scholar
• Nada MA, Chace DH, Sprecher H, et al. Investigation of P-oxidation intermediates in normal and MCAD-deficient human fibroblasts using tandem mass spectrometry. Biochem Mol Med 1995; 54: 59–66.
   Google Scholar
• Schmidt-Sommerfeld E, Bobrowski PJ, Penn D, et al. Analysis of carnitine esters by radio high-performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders. Pediatr Res 1998; 44: 210–4.
   Google Scholar
• Lehman TC, Hale DE, Bhala A, et al. An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. Anal Biochem 1990; 186: 280–4.
   PubMedGoogle Scholar
• Hale DE, Cornell JE, Bennett MJ. Stability of long-chain and short-chain 3-hydroxyacyl-CoA dehydrogenase activity in post-mortem liver. Clin Chem 1997; 43: 273–8.
   Google Scholar
• Bennett MJ, Allison F, Pollitt RJ, et al. Fatty acid oxidation disorders as causes of unexpected death in infancy. Prog Clin Biol Res 1990; 321: 349–66.
   PubMedGoogle Scholar
• Bennett MJ, Powell S. Metabolic disease and sudden unexpected death in infancy. Hum Pathol 1994; 25: 742–6.
   Google Scholar
• Boles RG, Martin SK, Blitzer MG, et al. Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of post-mortem liver. Hum Pathol 1994; 25: 735–41.
   PubMed Web of Science ®Google Scholar
• Boles RG, Buck EA, Blitzer MG, et al. Retrospective biochemical screening of fatty acid oxidation disorders in post mortem liver of 418 cases of sudden unexpected death in the first year of life. J Pediatr 1998; 132: 924–33.
   Google Scholar
• Rinaldo P, Yoon HR, Yu C, et al. Sudden and unexpected neonatal death: a protocol for the post mortem diagnosis of fatty acid oxidation disoders. Semin Perinatol 1999; 23: 204–10.
   Google Scholar
• Rashed MS, Ozand PT, Bennett MJ, et al. Fatty acid oxidation disorders and sudden death: diagnosis of inborn errors of metabolism in sudden death cases by acylcarnitine analysis of post mortem bile. Clin Chem 1995; 41: 1109–14.
   Google Scholar